Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Chemcel Biotech IPO.
September 13, 2024 11:39:33 PM
A trio of biotech companies� shares rose in their first trading sessions after they each sold more shares in their respective initial public offerings than they had planned.
Published by : Bloomberg on MSNSeptember 17, 2024 12:38:00 PM
With a trio of biotechs hitting the Nasdaq on Friday, it was easy to miss a smaller-scale public debut from another clinical-stage drug developer on the other side of the ESMO weekend. | With a trio ...
Published by : FierceBiotechSeptember 19, 2024 12:23:00 AM
BioAge Labs Inc., a clinical-stage biotechnology company developing therapies for obesity and metabolic disease, is seeking to raise as much as $157.5 million in its initial public offering and a ...
Published by : Bloomberg L.P.September 19, 2024 12:07:00 AM
Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial public offering in the United States, according to a regulatory filing.
Published by : ReutersSeptember 13, 2024 12:55:00 PM
It�s an unusually busy Friday for biotech IPOs, with Zenas BioPharma, MBX and Bicara Therapeutics all going public with fine-tuned offerings. | It�s a busy Friday for biotech IPOs, with Zenas ...
Published by : FierceBiotechSeptember 13, 2024 7:49:00 AM
A trio of biotech companies sold shares in their initial public offerings on Thursday, an encouraging sign for a sector whose new entrants have lately struggled.
Published by : Bloomberg L.P.September 13, 2024 4:38:00 PM
(Bloomberg) -- A trio of biotech companies� shares rose in their ... The company had expanded its IPO to sell 17.5 million shares at $18 each, at the top of the price range, to raise $315 ...
Published by : Yahoo FinanceSeptember 14, 2024 1:54:00 PM
A trio of biotech companies� shares rose in their first trading sessions after they each sold more shares in their respective initial public offerings (IPOs) than they had planned. Bicara Therapeutics ...
Published by : Business TimesSeptember 14, 2024 10:22:00 PM
The IPO raised $225 million, priced at $17 apiece, the middle of the marketed range. The offerings make this week the busiest for biotech and pharmaceuticals IPOs since July 2021, data compiled by ...
Published by : MintSeptember 13, 2024 7:39:00 PM
Zenas BioPharma Inc. shares increased 4.4% to $17.75 each. The IPO raised $225 million, priced at $17 apiece, the middle of the marketed range. The offerings make this week the busiest for biotech and ...
Published by : Yahoo FinanceChemcel Biotech Limited IPO stock listed today at a huge discount of around 68%. An Agro Chemicals manufacturer's fixed price IPO was priced at Rs 16 and closed for subscription on September 12.
Chemcel stock opened at its issue price of Rs 16 and then keeps falling all day. At one point the stock went down to its day low of Rs 4.75. Later the stock recovered a little and finally closed at Rs 5.25, around -68% from its issue price.
Most of the experts told investors not to apply in this IPO. The grey market premiums were running at Rs 2 to Rs 3 just before its listing.
Chemcel Biotech IPO Listing Date & Info:
IPO Listing Date: Monday, October 13, 2008
BSE Script Code: 533026
Listing in: 'B' Group of Securities
ISIN: INE213J01012
Issue Price: Rs 16/- Per Equity Share
Face Value: Rs 10/- Per Equity Share
IPO Allotment Status is now available online for Chemcel Biotech Limited IPO.
Chemcel Biotech IPO was open on September 09, 2008 and closed on September 12, 20.
The Chemcel Biotech IPO is proposed to open on September 9, 2008. The IPO application ends on September 12, 2008.
Retail investors can apply in the retail or non-institutional investor category from September 9, 2008 to September 12, 2008. The Chemcel Biotech IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Chemcel Biotech IPO will open for subscription on September 9, 2008. The public issue will close on September 12, 2008.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
